Forskningsgrupper
Forskningsprosjekter
Aktive forskningsprosjekter
-
Klinisk farmakologi og antiepileptika
Farmakologisk behandling med antiepileptika er utfordrende og krever individuell oppfølging.
Publikasjoner og forskningsresultater
Vitenskapelige publikasjoner
Heger, Katrine
; Burns, Margrete Larsen; Nikaronova, Marina; Johannessen, Svein Ivar;
Landmark, Cecilie Johannessen
(2024).
Pharmacokinetic Variability of Rufinamide and Stiripentol in Children With Refractory Epilepsy: A Retrospective Study of Therapeutic Drug Monitoring From the National Epilepsy Centers in Denmark and Norway.
7 s.
Therapeutic Drug Monitoring.
Vol. 46.
https://doi.org/10.1097/FTD.0000000000001219
Heger, Katrine
; Kjeldstadli, Kari Grandaunet; Ring, Nelly; Aaberg, Kari Modalsli; Kjeldsen, Signe Flood; Burns, Margrete Larsen; Johannessen, Svein Ivar;
Landmark, Cecilie Johannessen
(2023).
Pharmacokinetic Variability of Sulthiame: The Impact of Age, Drug-Drug Interactions, and Biochemical Markers of Toxicity in Patients with Epilepsy.
8 s.
Therapeutic Drug Monitoring.
Vol. 46.
https://doi.org/10.1097/FTD.0000000000001146
Heger, Katrine
; Skipsfjord, Julia;
Kiselev, Yury
; Burns, Margrete Larsen; Aaberg, Kari Modalsli; Johannessen, Svein Ivar;
Skurtveit, Svetlana Ondrasova
;
Landmark, Cecilie Johannessen
(2022).
Changes in the use of antiseizure medications in children and adolescents in Norway, 2009–2018.
8 s.
Epilepsy Research.
Vol. 181.
https://doi.org/10.1016/j.eplepsyres.2022.106872
Heger, Katrine
; Lund, Caroline; Burns, Margrete Larsen; Bjørnvold, Marit; Sætre, Erik; Johannessen, Svein Ivar;
Landmark, Cecilie Johannessen
(2020).
A retrospective review of changes and challenges in the use of
antiseizure medicines in Dravet syndrome in Norway.
Epilepsia Open.
https://doi.org/10.1002/epi4.12413
Landmark, Cecilie Johannessen
;
Heger, Katrine
; Lund, Caroline; Burns, Margrete Larsen; Bjørnvold, Marit; Sætre, Erik; Johannessen, Svein Ivar
(2020).
Pharmacokinetic Variability During Long-Term Therapeutic
Drug Monitoring of Valproate, Clobazam, and
Levetiracetam in Patients With Dravet Syndrome.
Therapeutic Drug Monitoring.
Vol. 42.
https://doi.org/10.1097/FTD.0000000000000781